NEW YORK, Sept 11 (Reuters) - A lawsuit alleging that Merck & Co's osteoporosis drug Fosamax caused jaw damage ended in a mistrial on Friday. U.S. District Judge John Keenan declared the mistrial two days giving the New York jury considering the case a "cooling off period" in light of supposed acrimony among jurors. A Merck lawyer on Wednesday referred to an "unsubstantiated claim" of a chair ...

[News Source]